For people with Parkinson’s disease and their families, there is rarely much good news.
The neurological condition slowly robs sufferers of their ability to move freely and live independently, causing worsening tremors and muscle stiffness – and, for some, problems with memory and thinking.
And despite 166,000 people in the UK now diagnosed, there is still no cure or approved drug capable of slowing its progression. But that, doctors cautiously suggest, may finally be about to change.
Experts speaking to The Mail on Sunday have revealed we are on the cusp of a revolution in Parkinson’s treatment, with a new generation of drugs
To provide well-rounded coverage and a breadth of insight across various events, we rely on contributions from several staff writers, each bringing their own area of expertise to our publication.